~~<i id='C5E8B74326'><strike id='C5E8B74326'><tt id='C5E8B74326'><pre id='C5E8B74326'></pre></tt></strike></i>~~

Home» focus» leisure time

leisure time

author：explore 2025-09-29 20:55:12 Page View：2726

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ASCO Takeaways: Winners, snoozers, and the art of cancer care
Next article： New air purifier tech could be key to improving indoor air quality

explore

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

Sutter Health’s antitrust win overturned by appeals court

AdobeWhenSutterHealthwasontrialforanticompetitiveconductin2022,theSanFranciscojurymissedoutonsomecru

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

How CO2 helps viruses stay alive longer in the air

AdobeCarbondioxidemonitorshavebeenaroundfordecades.Butin2020,theybecame,almostovernight,ahotcommodit